While I normally trust GlaxoSmithKline flu vaccines, they have had trouble with more side effects in some formulations of the H1N1.
Baxter makes a lot of IV fluids. I am unfamiliar with their vaccine branch since I don't think they have marketed flu vaccine in the US yet.
According to
this document, Celvapan is a whole virion product. Split virion flu vaccines have been associated with fewer side effects than whole virion.
Here is
the equivalent report on Pandemrix. Pandemrix is a split virion vaccine.
Unfortunately that makes it a wash. Split virion: less side effects; GSK, some batches may have had more side effects. I don't know if that included Pandemrix but you could probably find out with a quick Google search.
I'm sorry I don't have time to review those for you. You should look at antigen stimulation after the vaccine (effectiveness) and the side effect profiles. Be sure to compare the right age groups if the data is in there. Different ages respond differently to vaccines.
When they talk about the "mock up vaccine" that is one they developed by similar means long before the H1N1 pandemic.
So far, all the vaccines I am aware of are about the same in terms of risk and benefit. The FluMist is an exception in that it may be more effective in younger populations and less in older, but neither of these is FluMist type vaccine.
